Keppra and Epstein-barr virus infection - from FDA reports


Summary

Epstein-barr virus infection is found among people who take Keppra, especially for people who are female, 50-59 old , have been taking the drug for < 1 month, also take medication Diovan, and have Epilepsy . We study 34,747 people who have side effects while taking Keppra from FDA. Among them, 19 have Epstein-barr virus infection. Find out below who they are, when they have Epstein-barr virus infection and more.

What to expect?

If you take Keppra and have Epstein-barr virus infection, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Keppra and have Epstein-barr virus infection

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

Keppra

Keppra has active ingredients of levetiracetam. It is often used in epilepsy. (latest outcomes from Keppra 37,187 users)

Epstein-barr Virus Infection

Epstein-barr virus infection has been reported by people with rheumatoid arthritis, crohn's disease, kidney transplant, preventive health care, immunodeficiency disorders (latest reports from 2,954 Epstein-barr virus infection patients).

On Feb, 11, 2017

34,747 people reported to have side effects when taking Keppra.
Among them, 19 people (0.05%) have Epstein-barr Virus Infection


Number of reports submitted per year:

Could Keppra cause Epstein-barr virus infection?

Time on Keppra when people have Epstein-barr Virus Infection *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Epstein-barr Virus Infection when taking Keppra *:

  • female: 89.47 %
  • male: 10.53 %

Age of people who have Epstein-barr Virus Infection when taking Keppra *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 5.26 %
  • 20-29: 5.26 %
  • 30-39: 0.0 %
  • 40-49: 5.26 %
  • 50-59: 57.89 %
  • 60+: 26.32 %

Top conditions involved for these people *:

  • Epilepsy (12 people, 63.16%)
  • Multiple Sclerosis (11 people, 57.89%)
  • High Blood Pressure (11 people, 57.89%)
  • Hypothyroidism (9 people, 47.37%)
  • Glioma (3 people, 15.79%)

Top co-used drugs for these people *:

  • Diovan (11 people, 57.89%)
  • Sulfadiazine (8 people, 42.11%)
  • Venlafaxine Hydrochloride (3 people, 15.79%)
  • Simvastatin (3 people, 15.79%)
  • Dexamethasone (1 person, 5.26%)

Top other side effects for these people *:

  • Hemiparesis (12 people, 63.16%)
  • Central Nervous System Lesion (11 people, 57.89%)
  • Brain Mass (11 people, 57.89%)
  • Speech Impairment (adult) (10 people, 52.63%)
  • Blood Creatinine Increased (9 people, 47.37%)

* Approximation only. Some reports may have incomplete information.

** Reports from social media are used.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you have Epstein-barr virus infection when taking Keppra?

Browse all side effects of Keppra

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Epstein-barr virus infection

Epstein-barr virus infection

Could your condition cause Epstein-barr virus infection

Epstein-barr virus infection

Related studies

Can you answer these questions?

More questions for: Keppra, Epstein-barr virus infection

You may be interested in these reviews

More reviews for: Keppra, Epstein-barr virus infection